Poster Session 2-7 CML: Basic/Clinical

[PS2-7-3] An updated analysis of vascular adverse events in large cohort of TKI treated Japanese CML patients

Tomoiku Takaku¹, Isao Fujioka¹, Noriyoshi Iriyama², Michihide Tokuhira³, Yuta Kimura³, Eisaku Iwanaga⁴, Eriko Sato⁵, Maho Ishikawa⁶, Tomonori Nakazato⁷, Keiji Sugimoto⁸, Hiroyuki Fujita⁹, Norio Asou⁶, Masahiro Kizaki³, Yoshihiro Hatta², Norio Komatsu¹, Tatsuya Kawaguchi¹⁰ (1.Dept. Hematology, Juntendo University School of Medicine, Tokyo, Japan, 2.Div. Hematology & Rheumatology, Nihon University School of Medicine, Tokyo,, 3.Dept. Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan, 4.Dept. Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan, 5.Div. Hematology, Dept. Medicine, Juntendo University Nerima Hospital, Tokyo, Japan, 6.Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, 7.Dept. Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 8.Dept. Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan, 9.Dept. Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 10.Kumamoto Health Science University, Kumamoto, Japan)